Biochemistry and Molecular Biology Department, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
Stephenson Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
Cells. 2022 Jun 6;11(11):1855. doi: 10.3390/cells11111855.
p66Shc is a widely expressed protein that governs a variety of cardiovascular pathologies by generating, and exacerbating, pro-apoptotic ROS signals. Here, we review p66Shc's connections to reactive oxygen species, expression, localization, and discuss p66Shc signaling and mitochondrial functions. Emphasis is placed on recent p66Shc mitochondrial function discoveries including structure/function relationships, ROS identity and regulation, mechanistic insights, and how p66Shc-cyt c interactions can influence p66Shc mitochondrial function. Based on recent findings, a new p66Shc mitochondrial function model is also put forth wherein p66Shc acts as a rheostat that can promote or antagonize apoptosis. A discussion of how the revised p66Shc model fits previous findings in p66Shc-mediated cardiovascular pathology follows.
p66Shc 是一种广泛表达的蛋白,通过产生和加剧促凋亡的 ROS 信号来调控多种心血管疾病。在这里,我们综述了 p66Shc 与活性氧、表达、定位的关系,并讨论了 p66Shc 信号和线粒体功能。重点介绍了 p66Shc 线粒体功能的最新发现,包括结构/功能关系、ROS 的身份和调节、机制见解,以及 p66Shc-cyt c 相互作用如何影响 p66Shc 线粒体功能。基于最近的发现,还提出了一个新的 p66Shc 线粒体功能模型,其中 p66Shc 作为变阻器,可以促进或拮抗细胞凋亡。讨论了修正后的 p66Shc 模型如何适用于以前关于 p66Shc 介导的心血管病理学的发现。